Investor response to Emcure Pharmaceuticals IPO on the second bidding day was overwhelmingly positive, with the market as a whole being robust. The offering has flowed quite well thanks to the enthusiasm shown by non-institutional investors, individual investors, and qualified institutional buyers. The Pune-based company Emcure Pharmaceuticals is involved in […]

Emcure Pharmaceuticals IPO subscription status: The initial public offering of Emcure Pharmaceuticals Ltd kickstarts for subscriptions today (Wednesday, July 3). At an upper price range of ₹1,008 per equity share, Emcure Pharmaceuticals Ltd picked up ₹582 crore from 48 anchor investors, on Tuesday, July 2. Bain Capital-backed Emcure Pharmaceuticals IPO, […]

Bain Capital-backed Emcure Pharmaceuticals, on Tuesday, said that it has raised over ₹582 crore from anchor investors a day before its initial public offerings (IPO) opens for subscription. According to the exchange filing, the company has allocated 57,79,850 shares to 48 anchor investors at the price of ₹1,008 per share. […]